Cytosorbents Crp
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $9,485 | $9,617 | $8,727 | $9,150 |
Gross Profit | 6,666 | 6,814 | 6,207 | 9,398 |
EBITDA | -2,926 | -3,210 | -3,518 | -8,524 |
EBIT | -3,615 | -3,887 | -8,950 | |
Net Income | -3,170 | 1,947 | -1,478 | -7,883 |
Net Change In Cash | 9,485 | 9,617 | 8,727 | 9,150 |
Free Cash Flow | -2,522 | -1,546 | -3,512 | -2,466 |
Cash | 7,536 | 10,204 | 11,587 | 3,279 |
Basic Shares | 62,753 | 67,166 | 60,732 | 54,715 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $35,594 | $31,084 | $34,688 | $40,108 |
Gross Profit | 25,125 | 21,953 | 20,733 | 29,061 |
EBITDA | -15,215 | -27,879 | -30,003 | -21,615 |
EBIT | -16,785 | -29,902 | -30,885 | -22,744 |
Net Income | -20,718 | -29,246 | -32,812 | -24,558 |
Net Change In Cash | 35,594 | 31,084 | 34,688 | 40,108 |
Cost of Revenue | -29,730 | -17,596 | ||
Free Cash Flow | -14,712 | -22,591 | -34,689 | -18,286 |
Cash | 3,279 | 14,131 | 22,144 | 52,137 |
Basic Shares | 54,434 | 44,656 | 43,573 | 43,359 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.05 |
2025-06-30 | -$0.05 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.14 |
